Randox Laboratories
Bosch, Randox Laboratories to Invest €150M Into New PCR Tests for Vivalytic POC Platform
Starting with a rapid sepsis IVD test, the firms aim to expand the testing menu for Bosch'sVivalytic benchtop platform and become a market leader in point-of-care testing by 2030.
Randox Laboratories, Scienion Expand BioChip Manufacturing Collaboration for Rapid Diagnostic Testing
The firms said they will focus on increasing Randox’s manufacturing capacity for biochips including those used in SARS-CoV-2 tests.
Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity
The company said it is recruiting 200 staff members in science, engineering, and manufacturing to support its role within a national SARS-CoV-2 testing program.
Bosch Healthcare Solutions, Randox Laboratories Develop Coronavirus Test
The test, developed by the firms in six weeks, is part of a viral respiratory panel and runs on Bosch's point-of-care Vivalytic system.
Randox Laboratories STI Assay Gets CE Mark
The assay detects 10 STIs and is performed on the molecular point-of-care Vivalytic platform, which was codeveloped by German company Bosch.